Pamuk, G. E.Turgut, B.Demir, M.Vural, Oe.2024-06-122024-06-1220061756-9966https://hdl.handle.net/20.500.14551/18105It was reported that interieukin-10 (IL-10) level increased in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) patients; moreover this was associated with poor prognosis. In addition, it was stated that adiponectin induced the antiinflammatory cytokine IL-10. We evaluated adiponectin and IL-10 levels in NHL and CLL patients. We included newly diagnosed 28 NHL, 23 CLL patients, and 17 healthy subjects. In NHL patients, adiponectin level was higher than in CLL group and controls (p values <0.05). In CLL group, IL-10 level was lower than in NHL, and control groups (p values <0.05). Adiponectin level had a positive correlation with IL-10 level in the NHL patients (r=0.41, p=0.04). In the NHL group, the median survival of patients with high IL-10 levels was shorter (22 months vs. not reached, p=0.03). Increased IL-10 levels helped to predict poor outcome in our NHL patients. High adiponectin levels and a relationship between adiponectin/IL-10 in newly diagnosed NHL patients might suggest a role for both in the immunodysregulation in NHL.eninfo:eu-repo/semantics/closedAccessAdiponectinInterleukin-10Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaPrognosisClinical FeaturesChronic Lymphocytic-LeukemiaCellSerumIl-10ExpressionCytokinesSecreteDiseaseArticle254537541Q4WOS:00024373420001217310845